Lu-177-PSMA-617
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lu-177-PSMA-617, covering 2025-08-12 to 2026-03-23. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy [Phase 2]